BLSM
BlossomHill Therapeutics, Inc.
19.70$
+5.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
BlossomHill Therapeutics, Inc. (BLSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -11 | -9.1 | -21 | -23 | |
| 0.1 | 0.1 | 0.1 | 0.1 | |
| 0.2 | 0.3 | 0.3 | 0.6 | |
| -1.0 | 3.4 | -0.7 | 0.7 | |
| 0.4 | 0.6 | 0.0 | 0.0 | |
| -0.4 | – | 0.0 | – | |
| 0.0 | 0.0 | 0.3 | 2.6 | |
| -11 | -9.7 | -21 | -21 | |
| -11 | -9.7 | -21 | -23 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.